cbdMD (YCBD) Net Income (QoQ) (2017 - 2025)
cbdMD (YCBD) Net Income (QoQ) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.24 Bn | 87.37 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.17 Bn | 1.97 Bn |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.28 Bn | 21.13 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.54 Bn | 20.54 Bn | - |
| 7 | Viatris | 20.31 Bn | 18.50 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.55 Bn | 12.12 Bn | 785.00 Mn |
| 10 | cbdMD | 4.68 Mn | 1.30 Mn | 3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 58.36% |
| Sep 30, 2025 | 24.05% |
| Jun 30, 2025 | -86.22% |
| Mar 31, 2025 | -3,284.88% |
| Dec 31, 2024 | 109.88% |
| Sep 30, 2024 | -133.24% |
| Jun 30, 2024 | 115.27% |
| Mar 31, 2024 | -202.11% |
| Dec 31, 2023 | 93.72% |
| Sep 30, 2023 | -796.68% |
| Jun 30, 2023 | -32.44% |
| Mar 31, 2023 | 66.21% |
| Dec 31, 2022 | 72.96% |
| Sep 30, 2022 | 53.75% |
| Jun 30, 2022 | -579.25% |
| Mar 31, 2022 | 75.69% |
| Dec 31, 2019 | 98.33% |
| Sep 30, 2019 | -8.59% |
| Jun 30, 2019 | -376,514.26% |
| Mar 31, 2019 | -99.80% |